头雁|11月 18, 2026 08:15
The $5 billion funding round is likely the largest single investment in the history of biotechnology (combined with previous funding of approximately $60 million + $2.1 billion, bringing the total external funding to around $7.7 billion). The continued investment from top VCs and Alphabet demonstrates their strong confidence in AI's ability to "truly reshape drug discovery." The company positions itself as "an infrastructure company for drug discovery in the AI era." Its goal is to cure all human diseases.
The company's CEO, Demis Hassbis, may not be as famous as Musk, nor as adept at public relations, but this scientist, born in 1976, is the founder of Google's DeepMind.
- DeepMind was acquired by Google in 2014 (at the time, Google's largest acquisition in Europe), and he continued as CEO.
Key Achievements:
- AlphaGo (2016): First to defeat a human world Go champion.
- AlphaFold / AlphaFold 2: Solved the 50-year-old biological problem of protein structure prediction.
- Shared the 2024 Nobel Prize in Chemistry with John Jumper (for protein structure prediction), with the other half awarded to David Baker. - In 2021, he spun out of DeepMind to found Isomorphic Labs, which focuses on AI drug discovery, and served as its founder and CEO.
Share To
Timeline
HotFlash
APP
X
Telegram
CopyLink